Journal
JOURNAL OF THORACIC ONCOLOGY
Volume 12, Issue 1, Pages S506-S506Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2016.11.614
Keywords
tyrosine kinase inhibitor; EGFR mutation; p53 mutation; NSCLC